CRISPR Therapeutics (CRSP) Earnings Date, Estimates & Call Transcripts $50.40 +2.52 (+5.26%) (As of 11/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CRISPR Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 19EstimatedActual EPS (Nov. 5) -$1.01 Beat By $0.41 Consensus EPS (Nov. 5) -$1.42 CRISPR Therapeutics posted Q3 2024 earnings on November 5, 2024, reporting an EPS of -$1.01, which beat analysts' consensus estimates of -$1.42 by $0.41. Quarterly revenue was reported to be $0.60 million, below the consensus estimate of $6.65 million. With a trailing EPS of -$2.83, CRISPR Therapeutics' earnings are expected to decrease next year, from ($5.20) to ($5.31) per share. CRSP Upcoming EarningsCRISPR Therapeutics' next earnings date is estimated for Wednesday, February 19, 2025, based off prior year's reporting schedules. Get CRISPR Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CRISPR Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCRSP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRSP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsOne coin could soar when Trump’s elected …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. CRISPR Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244-$1.98-$1.19-$1.59Q2 20244-$1.98-$1.14-$1.63Q3 20244-$1.83-$1.18-$1.55Q4 20244-$1.57-$0.63-$1.27FY 202416-$7.36-$4.14-$6.04Q1 20252-$1.57-$1.29-$1.43Q2 20252-$1.56-$1.16-$1.36Q3 20252-$1.42-$1.04-$1.23Q4 20252-$1.33-$0.92-$1.13FY 20258-$5.88-$4.41-$5.15Q1 20261-$1.24-$1.24-$1.24Q2 20261-$0.86-$0.86-$0.86 CRISPR Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/19/2025(Estimated)------- 11/5/2024Q3 2024-$1.42-$1.01+$0.41-$1.01$6.65M$0.60M8/5/2024Q2 2024-$1.43-$1.49 -$0.06-$1.49$12.31M$0.52M 5/8/2024Q1 2024-$1.35-$1.43 -$0.08-$1.43$25.53M$0.50M 2/21/2024Q4 2023$0.15$1.10+$0.95$1.10$148.72M$201.20M 11/6/2023Q3 2023-$2.04-$1.41+$0.63-$1.41$5.05M- 8/7/2023Q2 2023-$2.13-$0.98+$1.15-$0.98$1.80M$70.00M Former Trump advisor issues urgent warning (Ad)Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now.5/8/2023Q1 2023-$1.64-$0.67+$0.97-$0.67$24.33M$100.00M 2/21/2023Q4 2022-$2.27-$1.41+$0.86-$1.41$7.37M$6.00M CRISPR Therapeutics Earnings - Frequently Asked Questions When is CRISPR Therapeutics's earnings date? CRISPR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates. Learn more on CRSP's earnings history. Did CRISPR Therapeutics beat their earnings estimates last quarter? In the previous quarter, CRISPR Therapeutics (NASDAQ:CRSP) reported ($1.01) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.42) by $0.41. Learn more on analysts' earnings estimate vs. CRSP's actual earnings. How much revenue does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded annual revenue of $371.21 million. How much profit does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded net income of -$153.61 million. CRSP has generated -$2.83 earnings per share over the last four quarters. What is CRISPR Therapeutics's EPS forecast for next year? CRISPR Therapeutics's earnings are expected to decrease from ($5.20) per share to ($5.31) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Moderna Earnings Date Neurocrine Biosciences Earnings Date Bio-Techne Earnings Date Vaxcyte Earnings Date Exelixis Earnings Date Qiagen Earnings Date Revolution Medicines Earnings Date Repligen Earnings Date Halozyme Therapeutics Earnings Date Krystal Biotech Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report One coin could soar when Trump’s elected … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. This page (NASDAQ:CRSP) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredWhat Are Buffett, Dalio, and Druckenmiller So Worried About?"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According t...Stansberry Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredI was wrong. Dead wrong. Deep inside Silicon Valley the alarm bells are ringing… Jeff Bezos just sold $3 billion in Amazon stock. ...Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRSP Stock Alerts